Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 11/20 | 0.48 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5536663 | 0.82 | ADRB3 (0.53) | ADRB3ADRB1ADRB2ADRA1DADRA1A | |
| SCHEMBL678588 | 0.75 | ADRB3 (0.56) | ADRB3ADRB1ADRB2ADRA1DADRA1A | |
| SCHEMBL2338083 | 0.71 | ADRB3 (0.60) | ADRB3ADRB1ADRB2ADRA1DADRA1A | |
| SCHEMBL29447016 | 0.67 | LMNA (0.64) | — | |
| SCHEMBL523934 | 0.67 | LMNA (0.64) | — | |
| Chlorobenzene SCHEMBL7068183 | 0.67 | ALOX15 (0.80) | ALDH1A1 | |
| Chlorobenzene SCHEMBL8616821 | 0.66 | ALOX15 (0.71) | ADRB3ADRB1ADRB2CYP1A2ALDH1A1 | |
| SCHEMBL7572345 | 0.65 | ADRB3 (0.40) | ADRB3ADRB1ADRB2 | |
| SCHEMBL1832083 | 0.65 | ALOX15 (0.77) | ALDH1A1 | |
| Alcohol SCHEMBL27641690 | 0.65 | ALOX15 (0.83) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070232698-A1 | Slimming Skin External Preparation and Cosmetic Containing the Same | SHOWA DENKO K.K. (JP) | 2007-10-04 | — | — | US | claimed |
| US-5626854-A | XANTHINE OR B-ADRENERGIC STIMULANT | KAO CORPORATION (JP) | 1997-05-06 | — | — | US | claimed |
| US-20070232698-A1 | Slimming Skin External Preparation and Cosmetic Containing the Same | SHOWA DENKO K.K. (JP) | 2007-10-04 | — | — | US | disclosed |
| WO-2001068137-A2 | COMPOSITIONS FOR REGULATING MEMORY CONSOLIDATION | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 2001-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232698-A1 | Slimming Skin External Preparation and Cosmetic Containing the Same | CPT1B, CUTA, LPL | ADRB3 1007/4885ADRB1 533/4885ADRB2 1058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.